Cargando…

Semiallogenic fusions of MSI(+ )tumor cells and activated B cells induce MSI-specific T cell responses

BACKGROUND: Various strategies have been developed to transfer tumor-specific antigens into antigen presenting cells in order to induce cytotoxic T cell responses against tumor cells. One approach uses cellular vaccines based on fusions of autologous antigen presenting cells and allogeneic tumor cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Garbe, Yvette, Klier, Ulrike, Linnebacher, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3192788/
https://www.ncbi.nlm.nih.gov/pubmed/21943054
http://dx.doi.org/10.1186/1471-2407-11-410
_version_ 1782213795843670016
author Garbe, Yvette
Klier, Ulrike
Linnebacher, Michael
author_facet Garbe, Yvette
Klier, Ulrike
Linnebacher, Michael
author_sort Garbe, Yvette
collection PubMed
description BACKGROUND: Various strategies have been developed to transfer tumor-specific antigens into antigen presenting cells in order to induce cytotoxic T cell responses against tumor cells. One approach uses cellular vaccines based on fusions of autologous antigen presenting cells and allogeneic tumor cells. The fusion cells combine antigenicity of the tumor cell with optimal immunostimulatory capacity of the antigen presenting cells. Microsatellite instability caused by mutational inactivation of DNA mismatch repair genes results in translational frameshifts when affecting coding regions. It has been shown by us and others that these mutant proteins lead to the presentation of immunogenic frameshift peptides that are - in principle - recognized by a multiplicity of effector T cells. METHODS: We chose microsatellite instability-induced frameshift antigens as ideal to test for induction of tumor specific T cell responses by semiallogenic fusions of microsatellite instable carcinoma cells with CD40-activated B cells. Two fusion clones of HCT116 with activated B cells were selected for stimulation of T cells autologous to the B cell fusion partner. Outgrowing T cells were phenotyped and tested in functional assays. RESULTS: The fusion clones expressed frameshift antigens as well as high amounts of MHC and costimulatory molecules. Autologous T cells stimulated with these fusions were predominantly CD4(+), activated, and reacted specifically against the fusion clones and also against the tumor cell fusion partner. Interestingly, a response toward 6 frameshift-derived peptides (of 14 tested) could be observed. CONCLUSION: Cellular fusions of MSI(+ )carcinoma cells and activated B cells combine the antigen-presenting capacity of the B cell with the antigenic repertoire of the carcinoma cell. They present frameshift-derived peptides and can induce specific and fully functional T cells recognizing not only fusion cells but also the carcinoma cells. These hybrid cells may have great potential for cellular immunotherapy and this approach should be further analyzed in preclinical as well as clinical trials. Moreover, this is the first report on the induction of frameshift-specific T cell responses without the use of synthetic peptides.
format Online
Article
Text
id pubmed-3192788
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31927882011-10-14 Semiallogenic fusions of MSI(+ )tumor cells and activated B cells induce MSI-specific T cell responses Garbe, Yvette Klier, Ulrike Linnebacher, Michael BMC Cancer Research Article BACKGROUND: Various strategies have been developed to transfer tumor-specific antigens into antigen presenting cells in order to induce cytotoxic T cell responses against tumor cells. One approach uses cellular vaccines based on fusions of autologous antigen presenting cells and allogeneic tumor cells. The fusion cells combine antigenicity of the tumor cell with optimal immunostimulatory capacity of the antigen presenting cells. Microsatellite instability caused by mutational inactivation of DNA mismatch repair genes results in translational frameshifts when affecting coding regions. It has been shown by us and others that these mutant proteins lead to the presentation of immunogenic frameshift peptides that are - in principle - recognized by a multiplicity of effector T cells. METHODS: We chose microsatellite instability-induced frameshift antigens as ideal to test for induction of tumor specific T cell responses by semiallogenic fusions of microsatellite instable carcinoma cells with CD40-activated B cells. Two fusion clones of HCT116 with activated B cells were selected for stimulation of T cells autologous to the B cell fusion partner. Outgrowing T cells were phenotyped and tested in functional assays. RESULTS: The fusion clones expressed frameshift antigens as well as high amounts of MHC and costimulatory molecules. Autologous T cells stimulated with these fusions were predominantly CD4(+), activated, and reacted specifically against the fusion clones and also against the tumor cell fusion partner. Interestingly, a response toward 6 frameshift-derived peptides (of 14 tested) could be observed. CONCLUSION: Cellular fusions of MSI(+ )carcinoma cells and activated B cells combine the antigen-presenting capacity of the B cell with the antigenic repertoire of the carcinoma cell. They present frameshift-derived peptides and can induce specific and fully functional T cells recognizing not only fusion cells but also the carcinoma cells. These hybrid cells may have great potential for cellular immunotherapy and this approach should be further analyzed in preclinical as well as clinical trials. Moreover, this is the first report on the induction of frameshift-specific T cell responses without the use of synthetic peptides. BioMed Central 2011-09-26 /pmc/articles/PMC3192788/ /pubmed/21943054 http://dx.doi.org/10.1186/1471-2407-11-410 Text en Copyright ©2011 Garbe et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Garbe, Yvette
Klier, Ulrike
Linnebacher, Michael
Semiallogenic fusions of MSI(+ )tumor cells and activated B cells induce MSI-specific T cell responses
title Semiallogenic fusions of MSI(+ )tumor cells and activated B cells induce MSI-specific T cell responses
title_full Semiallogenic fusions of MSI(+ )tumor cells and activated B cells induce MSI-specific T cell responses
title_fullStr Semiallogenic fusions of MSI(+ )tumor cells and activated B cells induce MSI-specific T cell responses
title_full_unstemmed Semiallogenic fusions of MSI(+ )tumor cells and activated B cells induce MSI-specific T cell responses
title_short Semiallogenic fusions of MSI(+ )tumor cells and activated B cells induce MSI-specific T cell responses
title_sort semiallogenic fusions of msi(+ )tumor cells and activated b cells induce msi-specific t cell responses
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3192788/
https://www.ncbi.nlm.nih.gov/pubmed/21943054
http://dx.doi.org/10.1186/1471-2407-11-410
work_keys_str_mv AT garbeyvette semiallogenicfusionsofmsitumorcellsandactivatedbcellsinducemsispecifictcellresponses
AT klierulrike semiallogenicfusionsofmsitumorcellsandactivatedbcellsinducemsispecifictcellresponses
AT linnebachermichael semiallogenicfusionsofmsitumorcellsandactivatedbcellsinducemsispecifictcellresponses